Geron Corporation Common Stock (GERN)

About GERN

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplasti…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

258

Website

www.geron.com/

Fundamentals

1-day range

$1.49$1.53

Market cap

$821.15M

P/E (trailing)

—

P/E (forward)

37.75

EPS (trailing)

$-0.10

Dividend yield

—

Beta

0.60

Avg. volume

11.61M

Forecasts

4 analyst ratings

Geron Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• GERN

  Geron Corporation Common Stock

  $1.51

  ▼ 1.63%
  Market cap $821.15MP/E —
  $1.04$2.01
• DSGN

  Design Therapeutics Inc. Common Stock

  $15.12

  ▼ 0.85%
  Market cap $796.95MP/E —
  $5.04$17.25
• ANNX

  Annexon Inc. Common Stock

  $4.97

  ▼ 5.33%
  Market cap $860.17MP/E —
  $2.03$7.18
• ACRS

  Aclaris Therapeutics Inc. Common Stock

  $6.01

  ▼ 2.44%
  Market cap $772.34MP/E —
  $1.74$6.6
• PHAR

  Pharming Group N.V. ADS each representing 10 ordinary shares

  $11.7

  ▼ 0.68%
  Market cap $766.28MP/E 88.15
  $0.8338$1.82
• AMPH

  Amphastar Pharmaceuticals Inc. Common Stock

  $22.01

  ▲ 0.59%
  Market cap $891.56MP/E 10.93
  $16.65$31.26
• MNPR

  Monopar Therapeutics Inc. Common Stock

  $112.17

  ▼ 1.55%
  Market cap $747.88MP/E —
  $32.77$124.82

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Geron Corp.: Management's Plan Taking Shape As Competition Heats Up In Myelofibrosis
  SeekingAlpha · 8/18/2026
• Geron (NASDAQ:GERN) Falls After Mixed Q2 Results; Revenue Beats but Loss Wider Than Expected
  ChartMill · 8/5/2026
• Geron Corporation (GERN) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/5/2026

• Robert J. Spiegel · June 30, 2026 · Grant

  6.1K @ $1.28
• Molineaux Susan · May 20, 2026 · Grant

  220.0K
• Robert J. Spiegel · May 20, 2026 · Grant

  220.0K
• McDonald John F · May 20, 2026 · Grant

  220.0K
• Elizabeth G. O'Farrell · May 20, 2026 · Grant

  220.0K
• Bir Dawn Carter · May 20, 2026 · Grant

  220.0K
• Timothy Williams · April 13, 2026 · Grant

  2.50M
• Robert J. Spiegel · March 31, 2026 · Grant

  5.2K @ $1.49
• Chinoporos Constantine · March 25, 2026 · Grant

  270.0K
• Patricia S. Andrews · March 25, 2026 · Grant

  270.0K

Institutional Ownership

March 31, 2026

Total shares held

489.41M

Total value held

$725.47M

Institutional holders

247